Salesforce (NYSE:CRM) just took a hit after its fiscal 2026 revenue forecast came in lighter than Wall Street hoped$40.5 billion to $40.9 billion versus the $41.4 billion consensus. First-quarter projections didn't impress either, and the stock slipped 3.7% at 10.15am. But here's the thing: most analysts aren't panicking. Of the 56 tracking the stock, 44 still have a Buy rating. Piper Sandler trimmed its price target slightly to $400 but kept its Overweight rating, pointing to AI monetization, multi-cloud adoption, and strong free cash flow as reasons to stay bullish.
Evercore sees this as a buying opportunity, arguing that revenue should pick up through the year while margins expand. The key driver? Agentforce. Salesforce's AI-powered automation tool has already locked in 5,000 deals and is expected to contribute meaningfully to revenue by 2026. William Blair analysts share the enthusiasm, seeing Agentforce as a major long-term play. Other firms like Scotiabank, Raymond James, and KeyBanc have adjusted price targets but remain optimistic about Salesforce's AI ambitions and enterprise dominance.
Not everyone's convinced, though. Guggenheim stands alone with a Sell rating and a $247 target, calling Salesforce overvalued and skeptical of its AI-driven growth potential. While free cash flow is strong and margins are improving, concerns around elongated sales cycles for core cloud services linger. Now, investors face a choicebuy the dip and ride the AI wave or wait for clearer signs of acceleration in the next earnings cycle.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.